Women's Health & Pregnancy Clinical Trials

Statistical methods in women's health & pregnancy trials

The methods these trials rely on most, based on the statistical analyses posted to ClinicalTrials.gov, with the tutorial that explains each one.

All women's health & pregnancy trials

490 results

• 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: Complete Statistical AnalysisIndependent statistical analysis of 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 2NCT02000596
• 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of 2 Phase Comparison of Pre-operative CT and PET Images for Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 21NCT01821105
• 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: Complete Statistical AnalysisIndependent statistical analysis of 4 Week Correction Study in Subjects With Anemia Associated With Chronic Kidney Disease Who Are Not Undergoing Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning…Phase 2Results postedn = 72NCT01587898
• 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: Complete Statistical AnalysisIndependent statistical analysis of 5% Lidocaine Ointment in the Treatment of Vulvar Vestibulitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00450242).Phase 2Results postedn = 14NCT00450242
• 6MPIndependent statistical analysis of A Clinical Trial in Patients With Breast Cancer Susceptibility Gene (BRCA) Defective Tumours: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 74NCT01432145
• A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease: Complete Statistical AnalysisIndependent statistical analysis of A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 154NCT01074125
• A Chatbot Intervention for Reducing HPV Vaccine Hesitancy: Complete Statistical AnalysisIndependent statistical analysis of A Chatbot Intervention for Reducing HPV Vaccine Hesitancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05959564).Phase NAResults postedn = 456NCT05959564
• A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study of Enlicitide in Participants With Severe Renal Impairment (MK-0616-032): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1Results postedn = 27NCT06643377
• A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Determine the Pharmacokinetics of Oraxol in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 1Results postedn = 28NCT03165955
• A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Evaluate Renal Hemodynamic Responses to Aliskiren in Patients With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 4Results postedn = 45NCT00660309
• A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 3Results postedn = 681NCT03213457
• A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 482NCT00373113
• A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 1/2Results postedn = 3NCT01312389
• A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Epizon-701 (EPN-701) in Subjects With End-Stage Renal Disease (ESRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 18NCT05285787
• A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 4Results postedn = 136NCT00830037
• A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 81NCT02481414
• A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease: Complete Statistical AnalysisIndependent statistical analysis of A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 140NCT05991726
• A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 1Results postedn = 40NCT02129205
• A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose Escalation/Expansion Study of Oral OP-1250 in Subjects With Advanced and/or Metastatic HR+, HER2- Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 1/2Results postedn = 153NCT04505826
• A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Dose-Escalation Study Evaluating the Combination of Trastuzumab Emtansine (T-DM1) With Neratinib in Women With Metastatic HER2-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size…Phase 1/2Results postedn = 49NCT02236000
• A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment: Complete Statistical AnalysisIndependent statistical analysis of A Dose-response Trial Using rFSH FE 999049 in Women Undergoing IVF/ICSI Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 265NCT01426386
• A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 3Results postedn = 596NCT01847274
• A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala: Complete Statistical AnalysisIndependent statistical analysis of A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase NAResults postedn = 100NCT02263118
• A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women: Complete Statistical AnalysisIndependent statistical analysis of A Multiple Dose Study of LY2541546 in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01742091).Phase 1Results postedn = 59NCT01742091
• A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.: Complete Statistical AnalysisIndependent statistical analysis of A Novel Approach for Reducing Hyperoxaluria and Kidney Stone Risk.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06481150).Phase 4Results postedn = 18NCT06481150
• A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 1Results postedn = 17NCT00623831
• A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1 Study Of Talazoparib, PARP Inhibitor, In Japanese Patients With Advanced Solid Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 1Results postedn = 28NCT03343054
• A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced Malignancies: Complete Statistical AnalysisIndependent statistical analysis of A Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected…Phase 1/2Results postedn = 222NCT03829501
• A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 10NCT02205476
• A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy: primary endpoint…Phase 2Results postedn = 226NCT01712061
• A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 22NCT02623972
• A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase 2Results postedn = 20NCT02019693
• A Phase 2b Diabetic Kidney Disease Study: Complete Statistical AnalysisIndependent statistical analysis of A Phase 2b Diabetic Kidney Disease Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04170543).Phase 2Results postedn = 609NCT04170543
• A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study of Solosec® for the Treatment of Trichomoniasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…Phase 3Results postedn = 147NCT03935217
• A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 3Results postedn = 479NCT04757376
• A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis: primary endpoint results, effect estimate with confidence interval,…Phase 3Results postedn = 432NCT02504294
• A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Akt Inhibitor MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval,…Phase 2Results postedn = 6NCT01283035
• A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC): Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…Phase 2Results postedn = 74NCT00726323
• A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Study of Paclitaxel and Carboplatin in Patients With an Elevated-Risk Cancer of the Uterus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…Phase 2Results postedn = 13NCT00584909
• A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma: Complete Statistical AnalysisIndependent statistical analysis of A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 30NCT00523640
• A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS): Complete Statistical AnalysisIndependent statistical analysis of A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS): primary endpoint results, effect estimate with confidence…Phase 2Results postedn = 17NCT02000440
• A Phase III Trial For Patients With Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Phase III Trial For Patients With Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00191152).Phase 3Results postedn = 475NCT00191152
• A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Clinical Trial of TENA Identifi in the Nursing Home Setting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase NAResults postedn = 49NCT03209570
• A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters: Complete Statistical AnalysisIndependent statistical analysis of A Pilot Study to Assess Effects of Self-Administered Nitrous Oxide (SANO) on Urodynamic Study (UDS) Parameters: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 4Results postedn = 19NCT05883332
• A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome: Complete Statistical AnalysisIndependent statistical analysis of A Randomized Controlled Trial Investigating if Antibiotic Use in the First 48 Hours of Life Adversely Impacts the Preterm Infant Microbiome: primary endpoint results, effect estimate with confidence…Phase NAResults postedn = 27NCT02477423
• A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations: Complete Statistical AnalysisIndependent statistical analysis of A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…Phase NAResults postedn = 611NCT01039584
• A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark: Complete Statistical AnalysisIndependent statistical analysis of A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in Denmark: primary endpoint results, effect estimate with…Phase NAResults postedn = 1,054NCT05452798
• A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis: Complete Statistical AnalysisIndependent statistical analysis of A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…Phase 2Results postedn = 27NCT01116440
• A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…Phase 2Results postedn = 131NCT02411110
• A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD): Complete Statistical AnalysisIndependent statistical analysis of A Safety and Tolerability Study of Zerenex (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…Phase 2Results postedn = 55NCT00648167

← All therapeutic areas